Longwood Fund
Longwood Fund is a venture capital firm that creates and invests in science-based healthcare companies. The firm co-founds and operationally supports companies (often taking CEO/CBO/President roles), partners with scientific co-founders, and runs value‑add programs and industry meetings to accelerate therapies from lab to patients.
Longwood Fund
Boston, Massachusetts, United States, North America
Services
Value-add investing and operational support
Provides capital plus operational support to portfolio companies, including company-building, strategic guidance, and hands-on leadership (acting as co-founding CEO, CBO, or President when appropriate).
Scientific co-founder partnerships and deal sourcing
Partners with world-class scientific co-founders to identify preclinical discoveries suitable for company formation and therapeutic development.
Network access and industry engagement
Hosts semi-annual industry meetings (Longwood Healthcare Leaders) and facilitates introductions to pharma, biotech, government, and academic leaders.
Growth-stage investment capability
Provides growth-stage capital and supports scaling through a dedicated growth-stage investment team.
Value-add investing and operational support
Provides capital plus operational support to portfolio companies, including company-building, strategic guidance, and hands-on leadership (acting as co-founding CEO, CBO, or President when appropriate).
Scientific co-founder partnerships and deal sourcing
Partners with world-class scientific co-founders to identify preclinical discoveries suitable for company formation and therapeutic development.
Network access and industry engagement
Hosts semi-annual industry meetings (Longwood Healthcare Leaders) and facilitates introductions to pharma, biotech, government, and academic leaders.
Growth-stage investment capability
Provides growth-stage capital and supports scaling through a dedicated growth-stage investment team.
Portfolio
Described as 'a new dawn for treatment of mental health conditions.'
#Neuroscience / Mental health
Targets sources of chronic inflammatory diseases.
#Chronic inflammatory diseases / Immunology
Advances and harnesses AI for drug discovery and development.
#Drug discovery / AI for drug discovery
Advancing small-molecule therapeutics targeting RAS and PI3K malignancies (example asset: BBO-10203).
#Oncology (small molecule targeted therapeutics)
Described as precision neuroscience developing transformational therapies.
#Precision neuroscience
Described as 'a new dawn for treatment of mental health conditions.'
#Neuroscience / Mental health
Targets sources of chronic inflammatory diseases.
#Chronic inflammatory diseases / Immunology
Advances and harnesses AI for drug discovery and development.
#Drug discovery / AI for drug discovery
Advancing small-molecule therapeutics targeting RAS and PI3K malignancies (example asset: BBO-10203).
#Oncology (small molecule targeted therapeutics)
Described as precision neuroscience developing transformational therapies.
#Precision neuroscience